12133-18-5 EuPt5
12133-28-7 CaH2S2
1213330-66-5 (R)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-aMine
12133-32-3 CaMg2
12133-44-7 CdP2
12133-50-5 Cadmium, compd. with copper (8:5)
121337-30-2 neutrophil activating peptide 2
12133-85-6 Cl14Ta6
125209-40-7 4H-Pyrido(1,2-a)pyrimidine-3-carboxylic acid, 4-oxo-9-((3-thiazolidiny lcarbonyl)thio)-, ethyl ester
125211-08-7 24-Norchola-5,20(22)-dieno[6,5,4-bc]furan-21,23-dioicacid,3-(acetyloxy)-14,15-epoxy-4,5,5',6-tetrahydro-7-hydroxy-4,8-dimethyl-1-[(2-methyl-1-oxo-2-butenyl)oxy]-16-oxo-,cyclic anhydride, [1a(E),3a,4b,5a,6b,7a,13a,14b,15b,17a]-
125211-18-9 2-Butanol, zirconium(4+) salt
125212-52-4 1-Butene, 1-cyclohexyl-2-diethylboryl-1-trimethylsilyl-, (E)-
125213-02-7 Thiophene, tetrahydro-3-nonyl-
125213-42-5 Methanesulfonic acid, trifluoro-, 4-(dimethylamino)phenyl ester
12521-45-8 Silanamine, 1-nitrilo-N-(nitrilosilyl)-, monolithium salt
125214-72-4 DL-PROTECTED MYO-INOSITOL
Serving Advanced Chemicals to Global Customers
© 2009 - 2025 USCKS | King-Pharm Ver 3.0